The big news of the day was the biotech sectors breakout, did you catch it? If you were watching the NASDAQ Biotech ETF (IBB), you didn’t, but if you watched the S&P Biotech SPDR ETF (XBI), you likely did. Meanwhile, the S&P 500 continues its grind higher, up fractionally today, and again getting closer to confirming the recent breakout.
Subscribe to get this commentary for Free.
Michael Kramer and the clients of Mott Capital own shares of CELG.
Disclaimer: Mott Capital Management, LLC is a registered investment adviser. Information presented is for educational purposes only and does not intend to make an offer or solicitation for the sale or purchase of any specific securities, investments, or investment strategies. Investments involve risk and unless otherwise stated, are not guaranteed. Be sure to first consult with a qualified financial adviser and/or tax professional before implementing any strategy discussed herein. Past performance is not indicative of future performance.